JEONG YEON LEE

Ms. JEONG YEON LEE

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
HYHyunjin Yeo
Hyunjin Yeo
SASung Shin Ahn
Sung Shin Ahn
JLJEONG YEON LEE
JEONG YEON LEE
SSSoon Young Shin
Soon Young Shin

30 June 2022 in Molecules
Verified
Journal Article
Open access
PDF file
JLJEONG YEON LEE
JEONG YEON LEE
EJEuitaek Jung
Euitaek Jung
HYHyunjin Yeo
Hyunjin Yeo
SASung Shin Ahn
Sung Shin Ahn
YLYoongho Lim
Yoongho Lim
YLYoung Han Lee
Young Han Lee
The circadian clock system is closely associated with inflammatory responses. Dysregulation of the circadian clock genes in the skin impairs the skin barrier function and affects the pathophysiology of atopic dermatitis. Interleukin 4 (IL-4) is a proinflammatory cytokine derived from T-helper type 2 cells; it plays a critical role in the pathogenesis of atopic dermatitis. Agerarin (6,7-dimethoxy-2,2-dimethyl-2H-chromene) is a natural JAK1/2/3 inhibitor isolated from Ageratum houstonianum that has a protective effect on the epidermal skin barrier. However, it remains unclear whether agerarin affects the circadian clock system. The aim of this study is to investigate the effect of agerarin on IL-4-induced PER2 gene expression in human keratinocytes through reverse transcription (RT)-PCR, quantitative real-time PCR (qPCR), immunoblotting, immunofluorescence microscopic analysis, and real-time bioluminescence analysis. We found that agerarin reduced IL-4-induced PER2 mRNA expression by suppressing the JAK-STAT3 pathway. In addition, real-time bioluminescence analysis in PER2:luc2p promoter-reporter cells revealed that agerarin restored the oscillatory rhythmicity of PER2 promoter activity altered by IL-4. These findings suggest that agerarin may be useful as a cosmeceutical agent against inflammatory skin conditions associated with disrupted circadian rhythms, such as atopic dermatitis.

2 July 2020 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
JLJEONG YEON LEE
JEONG YEON LEE
SASung Shin Ahn
Sung Shin Ahn
YJYou Jeong Jeong
You Jeong Jeong
JCJihye Choi
Jihye Choi
SASeunghyun Ahn
Seunghyun Ahn
SSSoon Young Shin
Soon Young Shin
Aurora kinases are Ser/Thr kinases that function as mitotic regulators. 5-Methoxy-2-(2-methoxynaphthalen-1-yl)-4H-chromen-4-one (DK1913) is a synthetic pan-Aurora kinase inhibitor. However, the mode of action of DK1913 concerning the induction of apoptosis is unclear. Here, we report that DK1913 triggered apoptosis, as revealed by flow cytometry and Annexin V staining. DK1913 enhanced the intracellular levels of reactive oxygen species (ROS) and stimulated the endoplasmic reticulum (ER) and genotoxic stress responses. We also found that DK1913 induced the loss of mitochondrial membrane potential, leading to the activation of caspase-9, caspase-7, and caspase-3. In addition, the antioxidant, butylated hydroxyanisole (BHA), abrogated DK1913-induced loss of mitochondrial membrane potential and activation of the caspase cascade. These findings demonstrate that pan-Aurora kinase inhibitor DK1913 triggers apoptosis through ROS-mediated ER and genotoxic stress responses.